H.R. 5547 · 118th Congress (2023–2025)
Maintaining Investments in New Innovation Act
This bill requires drug products with genetically targeted technology to have had market approval for at least 11 years in order to qualify for the Medicare Drug Price Negotiation Program. (The program requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation.)
Show official title
To amend title XI of the Social Security Act to protect access to genetically targeted technologies.
Expired in House committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to Health
This bill’s path
This is H.R. 5547’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
Expired
- Sponsor
- Rep. Wiley Nickel (D-NC-13)
- Cosponsors
28 cosponsors
2 original · 26 later
23 R · 5 D
- Rep. Donald G. Davis (D-NC-1)· Original · Sep 18, 2023
- Rep. John Joyce (R-PA-13)· Original · Sep 18, 2023
- Rep. Scott H. Peters (D-CA-50)· Later · Nov 1, 2023
- Rep. Dan Crenshaw (R-TX-2)· Later · Nov 14, 2023
- Rep. Larry Bucshon (R-IN-8)· Later · Nov 30, 2023
- Rep. Richard Hudson (R-NC-9)· Later · Dec 6, 2023
- Rep. A. Drew Ferguson IV (R-GA-3)· Later · Dec 11, 2023
- Rep. Rick W. Allen (R-GA-12)· Later · Feb 23, 2024
- Rep. Diana Harshbarger (R-TN-1)· Later · Mar 1, 2024
- Rep. Daniel Meuser (R-PA-9)· Later · Mar 19, 2024
- Rep. Blake D. Moore (R-UT-1)· Later · Mar 19, 2024
- Rep. Adrian Smith (R-NE-3)· Later · Mar 19, 2024
- Rep. Mariannette Miller-Meeks (R-IA-1)· Later · Mar 21, 2024
- Rep. Nicole Malliotakis (R-NY-11)· Later · Apr 10, 2024
- Rep. Vern Buchanan (R-FL-16)· Later · May 1, 2024
- Rep. Mike Carey (R-OH-15)· Later · May 15, 2024
- Rep. Beth Van Duyne (R-TX-24)· Later · May 15, 2024
- Rep. Sheila Cherfilus-McCormick (D-FL-20)· Later · May 23, 2024
- Rep. Mike Kelly (R-PA-16)· Later · May 23, 2024
- Rep. Lloyd Smucker (R-PA-11)· Later · Jun 14, 2024
- Rep. Michael C. Burgess (R-TX-26)· Later · Aug 27, 2024
- Rep. Neal P. Dunn (R-FL-2)· Later · Sep 10, 2024
- Rep. Josh Gottheimer (D-NJ-5)· Later · Sep 10, 2024
- Rep. Claudia Tenney (R-NY-24)· Later · Sep 10, 2024
- Rep. Kevin Hern (R-OK-1)· Later · Oct 29, 2024
- Rep. August Pfluger (R-TX-11)· Later · Oct 29, 2024
- Rep. Ken Calvert (R-CA-41)· Later · Dec 5, 2024
- Rep. Joseph D. Morelle (D-NY-25)· Later · Dec 5, 2024
- Policy area
- Health
- Subjects
- Genetics
- Medicare
- Prescription drugs
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
▸ 3 committee actions · Sep 18, 2023 – Dec 17, 2024
Referred to committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sources
- Congress.gov action
- House floor actions
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Expired
Introduced → Referred to House Health → No further action before the 118th Congress ended.
Committees
Feb 29, 2024 · Hearing
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
Maintaining Investments in New Innovation Act
Display title, Short title · Introduced in House
To amend title XI of the Social Security Act to protect access to genetically targeted technologies.
Official title · Introduced in House